Neutropenia refers to a group of diseases characterized by a reduction in neutrophil levels below the recommended age threshold. The present study aimed to review the diagnosis and management of neutropenia, including a diagnostic toolkit and candidate underlying genes. This study also aimed to review the progress toward the definition of autoimmune and idiopathic neutropenia rising in infancy or in late childhood but without remission, and provide suggestions for efficient diagnostics, including indications for the bone marrow and genetic testing. The management and treatment protocols for common and unique presentations are also reviewed, providing evidence tailored to a single patient.

Fioredda, F., Onofrillo, D., Farruggia, P., Barone, A., Veltroni, M., Notarangelo, L.d., et al. (2022). Diagnosis and management of neutropenia in children: The approach of the Study Group on Neutropenia and Marrow Failure Syndromes of the Pediatric Italian Hemato-Oncology Association (Associazione Italiana Emato-Oncologia Pediatrica - AIEOP). PEDIATRIC BLOOD & CANCER(6), e29599 [10.1002/pbc.29599].

Diagnosis and management of neutropenia in children: The approach of the Study Group on Neutropenia and Marrow Failure Syndromes of the Pediatric Italian Hemato-Oncology Association (Associazione Italiana Emato-Oncologia Pediatrica - AIEOP)

Finocchi, Andrea;
2022-06-01

Abstract

Neutropenia refers to a group of diseases characterized by a reduction in neutrophil levels below the recommended age threshold. The present study aimed to review the diagnosis and management of neutropenia, including a diagnostic toolkit and candidate underlying genes. This study also aimed to review the progress toward the definition of autoimmune and idiopathic neutropenia rising in infancy or in late childhood but without remission, and provide suggestions for efficient diagnostics, including indications for the bone marrow and genetic testing. The management and treatment protocols for common and unique presentations are also reviewed, providing evidence tailored to a single patient.
giu-2022
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA
English
Con Impact Factor ISI
children
granulocyte colony-stimulating factor
neutropenia
neutropenia diagnosis
neutropenia therapy
Fioredda, F., Onofrillo, D., Farruggia, P., Barone, A., Veltroni, M., Notarangelo, L.d., et al. (2022). Diagnosis and management of neutropenia in children: The approach of the Study Group on Neutropenia and Marrow Failure Syndromes of the Pediatric Italian Hemato-Oncology Association (Associazione Italiana Emato-Oncologia Pediatrica - AIEOP). PEDIATRIC BLOOD & CANCER(6), e29599 [10.1002/pbc.29599].
Fioredda, F; Onofrillo, D; Farruggia, P; Barone, A; Veltroni, M; Notarangelo, Ld; Menna, G; Russo, G; Martire, B; Finocchi, A; Verzegnassi, F; Bonanomi, S; Ramenghi, U; Pillon, M; Dufour, C
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Pediatric Blood Cancer - 2022 - Fioredda - Diagnosis and management of neutropenia in children The approach of the Study.pdf

solo utenti autorizzati

Descrizione: Articolo
Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 553.14 kB
Formato Adobe PDF
553.14 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/310266
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact